Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009-February 2011

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sharif, Salmaan ^a,b   Abbasi, Bilal Haider ^b   Khurshid, Adnan ^a   Alam, Muhammad Masroor ^a   Shaukat, Shahzad ^a   Angez, Mehar ^a   Rana, Muhammad Suleman ^a   Zaidi, Syed Sohail Zahoor ^a  

^a NATIONAL INSTITUTE OF HEALTH   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; PROTEIN VP1; 5' UNTRANSLATED REGION; PRIMER DNA; VIRUS DNA;

AFGHANISTAN; AMINO ACID SEQUENCE; ARTICLE; CHILD; EVOLUTION; FEMALE; FLACCID PARALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLIOMYELITIS VIRUS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; TYPE 2 CIRCULATING VACCINE DERIVED POLIOVIRUS; VIRUS CAPSID; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; 5' UNTRANSLATED REGION; CLASSIFICATION; DNA SEQUENCE; FECES; GENETICS; PAKISTAN; PATHOGENICITY; PHENOTYPE; POLIOMYELITIS; PRESCHOOL CHILD; SPECIES DIFFERENCE; VIROLOGY; VIRULENCE; WORLD HEALTH ORGANIZATION;

5' UNTRANSLATED REGIONS; AFGHANISTAN; CHILD, PRESCHOOL; DNA PRIMERS; DNA, VIRAL; FECES; FEMALE; HUMANS; INFANT; MALE; MUTATION; PAKISTAN; PHENOTYPE; PHYLOGENY; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; VIRULENCE; WORLD HEALTH ORGANIZATION;

EID: 84895864838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088442     Document Type: Article

References (39)

1. Agol VI (2006) Molecular mechanisms of poliovirus variation and evolution. Curr Top Microbiol Immunol 299: 211-259.
2. Bellmunt A, May G, Zell R, Pring- Akerblom P, Verhagen W, et al. (1999) Evolution of polio virus type 1 during 5.5 years of prolonged enteral replication in an immune deficient patient. Virology 265: 178-184. (Pubitemid 30022213)
3. Kew OM, Nottay BK (1984) Molecular epidemiology of polioviruses. Rev Infect Dis 6 Suppl 2: S499-504.
4. Centers for Disease C, Prevention (2007) Update on vaccine-derived polioviruses-worldwide, January 2006-August 2007. MMWR Morb Mortal Wkly Rep 56: 996-1001.
5. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, et al. (2004) Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82: 16-23. (Pubitemid 38220338)
6. Centers for Disease C, Prevention (2011) Update on vaccine-derived polioviruses-worldwide, July 2009-March 2011. MMWR Morb Mortal Wkly Rep 60: 846-850.
7. Update on vaccine-derived polioviruses. MMWR Morb Mortal Wkly Rep 55: 1093-1097.
8. Alexander JP, Ehresmann K, Seward J, Wax G, Harriman K, et al. (2009) Transmission of imported vaccine-derived poliovirus in an under-vaccinated community-Minnesota, USA. J Infect Dis 199: 391-397.
9. Centers for Disease C (2009) Update on Vaccine-Derived Polioviruses - Worldwide, January 2008-June 2009. MMWR Morb Mortal Wkly Rep 58: 1002-1006.
10. Update on vaccine-derived polioviruses-worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep 61: 741-746.
11. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, et al. (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296: 356-359. (Pubitemid 34303692)
12. Expanding contributions of the global laboratory network for poliomyelitis eradication, 2000-2001. Wkly Epidemiol Rec 77: 133-137.
13. Centers for Disease C (2012) Update on Vaccine-Derived Polioviruses - Worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep 61: 741-746.
14. Centers for Disease C (2006) Update on Vaccine-Derived Polioviruses. MMWR Morb Mortal Wkly Rep 55: 1093-1097.
15. INDIA POLIO FACT SHEET. Available: http://wwwpolioeradicationorg/Portals/ 0/Document/InfectedCountries/India/PolioIndiaFactSheetpdf. Accessed on June 10, 2013.
16. Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, et al. (2013) Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol 87: 4907-4922.
17. Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, et al. (2010) Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 362: 2360-2369.
18. Polio laboratory manual - World Health Organization. WHO/IVB/0410 4. 2004
19. Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, et al. (2005) Rapid Group-, Serotype-, and Vaccine Strain-Specific Identification of Poliovirus Isolates by Real-Time Reverse Transcription-PCR Using Degenerate Primers and Probes Containing Deoxyinosine Residues. J Virol 79: 12623-12634.
20. Guillot S, Caro V, Cuervo N, Korotkova E, Combiescu M, et al. (2000) Natural Genetic Exchanges between Vaccine and Wild Poliovirus Strains in Humans. J Virol 74: 8434-8443. (Pubitemid 30666694)
21. Zurbriggen S, Tobler K, Abril C, Diedrich S, Ackermann M, et al. (2008) Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl Environ Microbiol 74: 5608-5614.
22. Karakasiliotis I, Paximadi E, Markoulatos P (2005) Evolution of a rare vaccine-derived multirecombinant poliovirus. J Gen Virol 86: 3137-3142. (Pubitemid 41555580)
23. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
24. Li WH, Ellsworth DL, Krushkal J, Chang BH, Hewett-Emmett D (1996) Rates of nucleotide substitution in primates and rodents and the generation-time effect hypothesis. Mol Phylogenet Evol 5: 182-187. (Pubitemid 126317003)
25. Jorba J, Campagnoli R, De L, Kew O (2008) Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 82: 4429-4440. (Pubitemid 351563679)
26. Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ (2003) Polio eradication: the OPV paradox. Rev Med Virol 13: 277-291. (Pubitemid 37082191)
27. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, et al. (1985) The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance-a review. Gene 40: 1-8. (Pubitemid 16132020)
28. Kinnunen L, Huovilainen A, Poyry T, Hovi T (1990) Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J Gen Virol 71 (Pt 2): 317-324. (Pubitemid 20059128)
29. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59: 587-635. (Pubitemid 41507443)
30. Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, et al. (2003) Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77: 8366-8377. (Pubitemid 36871465)
31. Progress towards poliomyelitis eradication in Afghanistan and Pakistan, 2008. Wkly Epidemiol Rec 84: 77-83.
32. Afghanistan W (2011) Report on Vaccine Derived polio Virus (VDPV) type 2 cases from Nade Ali/Marja district Helamand province during 2010-11 in Southern region of Afghanistan. Available: http://wwwpolioeradicationorg/ Infectedcountries/Afghanistanaspx. Accessed on June 10, 2013.
33. Rakoto-Andrianarivelo M, Gumede N, Jegouic S, Balanant J, Andriamamonjy SN, et al. (2008) Reemergence of recombinant vaccine-derived polivirus outbreak in Madagascar. J Infect Dis 197, 1427-1435. (Pubitemid 351706467)
34. Avellón A, Cabrerizo M, de Miguel T, Pérez-Breña P, Tenorio A, et al. (2008) Paralysis case andcontact spread of recombinant vaccine-derived poliovirus, Spain. Emerg Infect Dis 14: 1807-1809.
35. Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, et al. (2003) Recombinant vaccine derived polioviruses in Madagascar. Emerging Infectious Diseases 9.
36. Razafindratsimandresy R, Joffret ML, Rabemanantsoa S, Andriamamonjy S, Heraud JM, et al. (2013) Reemergence of Recombinant Vaccine-derived Polioviruses in Healthy Children, Madagascar. Emerging Infectious Diseases 19.
37. Gavrilin GV, Cherkasova EA, Lipskaya GY, Kew OM, Agol VI (2000) Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74: 7381-7390. (Pubitemid 30613083)
38. Friedrich F (2000) Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus. Acta Virol 44: 109-117.
39. Shulman LM, Manor Y, Handsher R, Delpeyroux F, McDonough MJ, et al. (2000) Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol 38: 3729-3734.